Does a mean pulmonary artery pressure of 70 mmHg with a pulmonary artery wedge pressure of 21 mmHg and a normal left ventricular end‑diastolic pressure of 12 mmHg, in the absence of mitral valve disease or left atrial enlargement, meet the hemodynamic criteria for Group 2 pulmonary hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemodynamic Diagnosis of Group 2 Pulmonary Hypertension

No, these hemodynamics do not meet diagnostic criteria for Group 2 pulmonary hypertension because the PAWP of 21 mmHg exceeds the diagnostic threshold of ≤15 mmHg required for Group 2 PH, and the discrepancy between PAWP (21 mmHg) and LVEDP (12 mmHg) indicates unreliable wedge pressure measurement that requires direct left ventricular pressure assessment. 1

Critical Hemodynamic Discrepancy

The 9 mmHg difference between your PAWP (21 mmHg) and LVEDP (12 mmHg) represents a significant measurement error that invalidates the PAWP reading. 1

  • When PAWP is unreliable or discrepant with clinical findings, direct left heart catheterization to measure LVEDP is recommended. 1
  • The European Society of Cardiology guidelines specifically state that when measurement of PAWP is unreliable, left heart catheterization should be considered to measure LVEDP. 1
  • This discrepancy suggests technical issues with wedge pressure measurement, such as improper catheter position, overwedging, or pulmonary vein obstruction. 2

Correct Diagnostic Classification Using LVEDP

Using the accurate LVEDP of 12 mmHg (rather than the erroneous PAWP of 21 mmHg), this patient has:

  • Mean PAP: 70 mmHg (severely elevated)
  • LVEDP: 12 mmHg (normal, ≤15 mmHg)
  • This defines pre-capillary pulmonary hypertension (Group 1,3,4, or 5), NOT Group 2 PH. 1

Hemodynamic Definitions for Group 2 PH

Group 2 PH (post-capillary pulmonary hypertension) requires ALL of the following criteria:

  • Mean PAP ≥25 mmHg (older definition) or >20 mmHg (2022 definition) 1, 3, 4
  • PAWP >15 mmHg (this is the defining feature of post-capillary PH) 1, 3, 4
  • The elevated PAWP reflects backward transmission of elevated left heart pressures 3, 4, 5

Your patient's true LVEDP of 12 mmHg excludes Group 2 PH by definition. 1

Subclassification of Group 2 PH (When Criteria Are Met)

If PAWP were truly >15 mmHg, Group 2 PH is further classified as:

  • Isolated post-capillary PH (IpcPH): DPG <7 mmHg and/or PVR ≤3 Wood units 1, 3, 4
  • Combined pre- and post-capillary PH (CpcPH): DPG ≥7 mmHg and/or PVR >3 Wood units 1, 3, 4

Calculate PVR to Determine Pre-Capillary Component

Using the correct LVEDP of 12 mmHg:

  • PVR = (mPAP - LVEDP) / Cardiac Output
  • PVR = (70 - 12) / CO = 58 / CO 2
  • If cardiac output is 5 L/min: PVR = 11.6 Wood units (severely elevated, indicating pre-capillary disease) 2
  • Normal PVR is <2-3 Wood units; PVR >3 Wood units defines pre-capillary pulmonary vascular disease 1, 2

Clinical Implications of This Hemodynamic Profile

This patient has severe pre-capillary pulmonary hypertension with:

  • Markedly elevated mean PAP (70 mmHg) with normal left heart filling pressures (LVEDP 12 mmHg) 1
  • Absence of mitral valve disease and left atrial abnormality further supports pre-capillary etiology 1
  • This hemodynamic profile suggests Group 1 (pulmonary arterial hypertension), Group 3 (lung disease), Group 4 (chronic thromboembolic PH), or Group 5 (miscellaneous) 1

Diagnostic Algorithm Moving Forward

Step 1: Repeat right heart catheterization with careful attention to wedge pressure technique 1, 2

  • Zero the transducer at mid-thoracic line 2
  • Confirm proper wedge position with blood gas showing arterialized blood 2
  • Measure at end-expiration during spontaneous breathing 2
  • If PAWP remains discrepant, directly measure left atrial pressure or LVEDP 1

Step 2: If LVEDP remains ≤15 mmHg, pursue workup for pre-capillary PH 1

  • Ventilation-perfusion scan to exclude chronic thromboembolic disease (Group 4) 1
  • High-resolution chest CT to evaluate for interstitial lung disease (Group 3) 1
  • Serologic testing for connective tissue disease (Group 1) 1
  • Consider vasoreactivity testing if idiopathic PAH is suspected 1

Step 3: Echocardiographic features that would suggest occult left heart disease despite normal LVEDP 1

  • Left atrial enlargement >4.2 cm 1
  • Increased E/e' ratio suggesting diastolic dysfunction 1
  • Concentric left ventricular hypertrophy 1
  • However, your patient lacks mitral valve disease and left atrial abnormality, making occult Group 2 PH unlikely 1

Common Pitfalls in PAWP Measurement

Several technical factors can cause falsely elevated PAWP readings:

  • Overwedging: Balloon inflation in too distal a position creates artificially high pressure 2
  • Catheter tip position: Measurements in West lung zones 1 or 2 overestimate left atrial pressure 2
  • Respiratory variation: Failure to measure at end-expiration causes inaccurate readings 2
  • V-wave inclusion: Large V-waves in the wedge tracing can elevate mean PAWP without reflecting true LVEDP 2

The 9 mmHg gradient between your PAWP and LVEDP strongly suggests one of these technical errors occurred. 1, 2

Why Normal LVEDP Excludes Group 2 PH Despite Elevated PAWP

The fundamental pathophysiology of Group 2 PH is passive backward transmission of elevated left heart pressures into the pulmonary circulation. 3, 4, 5

  • If LVEDP is normal (12 mmHg), there is no elevated left heart pressure to transmit backward 3, 4
  • The absence of mitral valve disease eliminates valvular obstruction as a cause of elevated left atrial pressure with normal LVEDP 1
  • The absence of left atrial abnormality makes left atrial myopathy or restrictive physiology unlikely 1
  • Therefore, the erroneous PAWP of 21 mmHg must be disregarded in favor of the directly measured LVEDP of 12 mmHg 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Calculation of Pulmonary and Systemic Vascular Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Diagnostic Challenge of Group 2 Pulmonary Hypertension.

Progress in cardiovascular diseases, 2016

Research

Pulmonary hypertension in left heart disease.

European respiratory review : an official journal of the European Respiratory Society, 2012

Related Questions

What is the treatment for Group 2 pulmonary hypertension?
What is the difference between mean pulmonary artery pressure and pulmonary capillary wedge pressure in diagnosing pulmonary hypertension?
Do pulmonary hypertension (PHTN) and left atrial enlargement (LAE) classify a patient as having Stage B heart failure?
What are examples of group 2 pulmonary hypertension?
What is the most likely cause of pulmonary hypertension in a patient with a low ejection fraction (EF), atrial fibrillation (AF), and ischemic heart disease (IHD)?
What is Hanks' Balanced Salt Solution, its composition and storage conditions, and is it appropriate for intravenous or in‑vivo therapeutic use?
What is the typical size of individual measles (rubeola) rash lesions in an infant?
How should I manage a patient with acute kidney disease who is worsening, evidenced by rising serum creatinine, declining eGFR, oliguria, electrolyte abnormalities, or new uremic symptoms?
How should measles be diagnosed, isolated, treated, and prevented, including vitamin A dosing and post‑exposure prophylaxis for unvaccinated individuals?
What is the term for worsening acute kidney disease (AKD) indicated by rising serum creatinine, decreasing eGFR, oliguria, new electrolyte disturbances, or uremic symptoms?
In a diabetic patient with a urine albumin‑creatinine ratio of approximately 27,500 µg/mg (nephrotic‑range proteinuria), normal serum creatinine (0.7 mg/dL) and no diabetic retinopathy, what is the likely diagnosis and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.